MATRIX PHARMACY LIMITEDActive
Key figures
MATRIX PHARMACY LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2025/26Balance sheet structure
Dividends
from the accountsDividends paid in the financial year: £127,000 (62% of the profit for the year).
Filed accounts2020/21–2025/26
| 2020/21 | 2021/22 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|---|
| Profit for the year | 248,906 | 385,621 | 132,027 | 48,710 | 204,645 |
| Cash at bank and in hand | 304,459 | 1,183,970 | 884,807 | 414,732 | 640,868 |
| Total assets | 3,887,674 | 4,202,408 | 3,879,454 | 3,814,100 | 3,996,290 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | 2,270,619 | 2,536,849 | 2,500,606 | 2,413,316 | 2,490,961 |
| Average number of employees | 19 | 45 | 50 | 51 | 66 |
| Dividends paid | — | 119,391 | 134,000 | 136,000 | 127,000 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: MATRIX PHARMACY LIMITED
Company
MATRIX PHARMACY LIMITED is a private limited company registered with Companies House under company number 04679847. It was incorporated on 26 Feb 2003. Its status is active. The registered office is in Walsall (WS5). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Mar 2026); the company files small company accounts (filleted). Profit for the year was £204,645. Net assets were £2,490,961, up 3.2% on the previous year. Cash at bank and in hand was £640,868. The company had an average of 66 employees. Figures are available for 5 financial years (2020/21–2025/26).
Control and charges
One person with significant control is registered. 6 of 6 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Dec 2027. The next confirmation statement is due by 12 Mar 2027.